Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells. 1998

M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
Department of Internal Medicine, University Hospital Maastricht, The Netherlands. maurice.jansen@molcelb.unimaas.nl

Hodgkin and Reed-Sternberg cells are considered to represent the malignant fraction in Hodgkin's disease. Several studies have shown that the Hodgkin and Reed-Sternberg cells are chromosomally abnormal, but genetic data about the morphologically normal cell population in Hodgkin's disease are very limited. This latter cell population has therefore been examined for chromosomal aberrations, using the in situ hybridization (ISH) procedure, making use of DNA probes for chromosomes 1, 7, 8, 9, 11, 12, 15, 17, and 18. Nuclei were isolated from freshly frozen (10 cases) and paraffin-embedded (16 cases) biopsy samples and 1000 nuclei per case were evaluated. The cases of Hodgkin's disease were compared with reactive lymph nodes, which show aberrant chromosome copy numbers in less than 1 per cent of the cells. Using strict scoring criteria, nuclei in the tumour were found to show an abnormal genotype, in the range of 1-12 per cent, with trisomies occurring most frequently. No characteristic numerical chromosome abnormality was observed. ISH on 4 microns thick paraffin sections of six cases of Hodgkin's disease revealed numerical aberrations for chromosome 1 in cells which appeared to be morphologically normal. The genomically abnormal nuclei did not differ in morphology or size from the nuclei of morphologically normal cells, but differed considerably in size when compared with the nuclei of Hodgkin/Reed-Sternberg cells after the ISH procedure. Three of these six cases revealed a population of apparently normal cells with an aberrant copy number which differed notably from the fraction observed in reactive lymph nodes. It is concluded, therefore, that a subset of morphologically normal cells, next to the Hodgkin/Reed-Sternberg cells, are chromosomally aberrant and may participate in the malignant cell fraction of Hodgkin's disease.

UI MeSH Term Description Entries
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016539 Reed-Sternberg Cells Large cells, usually multinucleate, whose presence is a common histologic characteristic of classical HODGKIN DISEASE. Sternberg-Reed Cells,Cells, Reed-Sternberg,Cells, Sternberg-Reed,Reed Sternberg Cells,Sternberg Reed Cells
D017403 In Situ Hybridization A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. Hybridization in Situ,Hybridization, In Situ,Hybridizations, In Situ,In Situ Hybridizations

Related Publications

M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
January 1998, Annual review of immunology,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
October 1994, Proceedings of the National Academy of Sciences of the United States of America,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
February 1994, British journal of haematology,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
June 1999, Cancer treatment reviews,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
May 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
May 1972, California medicine,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
April 2000, Histopathology,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
January 2017, Blood,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
January 1997, International ophthalmology,
M P Jansen, and A H Hopman, and A M Haesevoets, and I A Gennotte, and F J Bot, and J W Arends, and F C Ramaekers, and H C Schouten
November 2006, Cancer research,
Copied contents to your clipboard!